ATE439127T1 - Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich - Google Patents

Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich

Info

Publication number
ATE439127T1
ATE439127T1 AT03732804T AT03732804T ATE439127T1 AT E439127 T1 ATE439127 T1 AT E439127T1 AT 03732804 T AT03732804 T AT 03732804T AT 03732804 T AT03732804 T AT 03732804T AT E439127 T1 ATE439127 T1 AT E439127T1
Authority
AT
Austria
Prior art keywords
cosmetic
treatment
compounds
coon
prevention
Prior art date
Application number
AT03732804T
Other languages
English (en)
Inventor
Giancarlo Cravotto
Original Assignee
Medestea Res & Production S P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2002TO000521A external-priority patent/ITTO20020521A1/it
Priority claimed from ITTO20021049 external-priority patent/ITTO20021049A1/it
Application filed by Medestea Res & Production S P filed Critical Medestea Res & Production S P
Application granted granted Critical
Publication of ATE439127T1 publication Critical patent/ATE439127T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT03732804T 2002-06-17 2003-06-16 Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich ATE439127T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002TO000521A ITTO20020521A1 (it) 2002-06-17 2002-06-17 Procedimento per la preparazione di acidi policosanoici e policosanoli
ITTO20021049 ITTO20021049A1 (it) 2002-12-03 2002-12-03 Composti ossigenati insaturi a lunga catena e loro impiego in campo terapeutico, cosmetico e nutraceutico.
PCT/IB2003/002317 WO2003105822A1 (en) 2002-06-01 2003-06-16 Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field

Publications (1)

Publication Number Publication Date
ATE439127T1 true ATE439127T1 (de) 2009-08-15

Family

ID=29738175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03732804T ATE439127T1 (de) 2002-06-17 2003-06-16 Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich

Country Status (10)

Country Link
US (1) US7649103B2 (de)
EP (1) EP1515714B1 (de)
CN (1) CN1665495A (de)
AT (1) ATE439127T1 (de)
AU (2) AU2003240187A1 (de)
DE (1) DE60328785D1 (de)
ES (1) ES2329888T3 (de)
PT (1) PT1515714E (de)
RU (1) RU2331415C2 (de)
WO (2) WO2003105822A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1685089A1 (de) * 2003-11-17 2006-08-02 DSM IP Assets B.V. Verfahren zur herstellung aliphatischer primärer alkohole, und zwischenprodukte in einem solchen verfahren
WO2006042835A1 (en) * 2004-10-18 2006-04-27 Dsm Ip Assets B.V. Process for the preparation of aliphatic primary alcohols and related intermediates in such process
WO2009133586A1 (ja) * 2008-04-28 2009-11-05 有限会社アンティアンティ アルツハイマー病の治療医薬
WO2010103549A2 (en) * 2009-03-12 2010-09-16 Godavari Biorefineries Ltd A method of obtaining policosanols from natural material
FR2950061B1 (fr) 2009-09-11 2013-12-20 Coatex Sas Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations
CN102115425A (zh) * 2009-12-30 2011-07-06 重庆华邦胜凯制药有限公司 一种直链烯醇及其制备方法
CN103153936B (zh) * 2010-10-01 2016-08-03 帝斯曼知识产权资产管理有限公司 改进的培瑞维a酸的合成
AU2012211854A1 (en) * 2011-01-31 2013-08-08 Nagoya Industrial Science Research Institute Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
SU1537264A1 (ru) * 1985-07-09 1990-01-23 Томский Медицинский Институт Способ коррекции иммунной недостаточности у детей с ожирением
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
RU2113853C1 (ru) * 1995-11-24 1998-06-27 Татьяна Всеволодовна Тимофеева Препарат "курдлипид"
RU2063766C1 (ru) * 1995-12-19 1996-07-20 Индивидуальное частное предприятие "Лечебно-оздоровительный комплекс доктора Клюсса" Способ оздоровления организма
BR9710394A (pt) * 1996-07-23 2000-01-11 Nagase Biochemicals Ltda Processo para preparação de ácido docosahexaenóico e ácido docosapentaenóico;processo de preparação a partir de lipidio;microorganismo produtor de lipìdios;alimentos e congenêres abtidos através do processo
CU22723A1 (es) * 1997-04-02 2002-02-28 Dalmer Lab Sa Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
CA2340223A1 (en) * 1998-08-12 2000-02-24 Morinaga Milk Industry Co., Ltd. Nutritional compositions for preventing or treating hyperlipoproteinemia
GB9916536D0 (en) * 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
CA2290885A1 (fr) * 1999-12-02 2001-06-02 Universite De Sherbrooke Methode pour la transformation des tissus du loup marin
DK1121928T3 (da) * 2000-01-31 2008-03-17 Haerting S A Sammensætninger indeholdende phytosterol- og policosanolestere af fedtsyrer til reduktion af niveauet af blodcholesterol og -triglycerider
JP2002069111A (ja) * 2000-06-13 2002-03-08 Japan Science & Technology Corp 重合分子鎖の作成方法

Also Published As

Publication number Publication date
WO2003105822A1 (en) 2003-12-24
PT1515714E (pt) 2009-10-06
WO2003106397A1 (en) 2003-12-24
EP1515714A1 (de) 2005-03-23
EP1515714B1 (de) 2009-08-12
ES2329888T3 (es) 2009-12-02
US7649103B2 (en) 2010-01-19
RU2005100847A (ru) 2005-10-10
US20050234127A1 (en) 2005-10-20
RU2331415C2 (ru) 2008-08-20
WO2003105822A8 (en) 2004-04-08
AU2003240187A1 (en) 2003-12-31
AU2003240189A1 (en) 2003-12-31
CN1665495A (zh) 2005-09-07
DE60328785D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
Zeng et al. Mechanisms of action involved in ozone-therapy in skin diseases
Galanakis et al. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity
US6703031B1 (en) Cysteine derivatives
UA109252C2 (uk) Сірковмісні ліпіди для застосування як харчових добавок або медикаментів
BR9807443A (pt) Processos para reduzir a incidência de enterocolite necrótica em uma criança e para a produção de uma fórmula enteral, e, fórmulas enteral aperfeiçoada contendo ácido araquidÈnico e ácido docosaexaenóico e adequada para alimentar crianças.
EP1392282A2 (de) Dermatologische und kosmetische zusammensetzungen
ES2129013B1 (es) Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.
US6177470B1 (en) Methods of treatment using ascorbyl gamma linolenic acid or ascorbyl dihomo-gamma-linolenic acid
EP2272383A1 (de) Zusammensetzung, die Omega-7- und/oder Omega-4-Fettsäuren enthält
DE60328785D1 (de) Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich
US8835496B2 (en) Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride for treating of skin, mucosa, hair, nails, or scalp
US20160243011A1 (en) Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof
CN1265580A (zh) 含巯基葡聚糖的皮肤增白组合物
BR112012007350A8 (pt) Composição de cristal líquido
JP5587333B2 (ja) 抗アクネ剤としての多価不飽和脂肪酸およびジオールエステル
JPH02200621A (ja) 外用剤
AU2016219617A1 (en) Positively charged water-soluble prodrugs of aspirin
ATE43348T1 (de) Acylierte cytidin-diphosphat-choline, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
FR2495608A1 (fr) Nouveaux derives de l'acide aspartique et leurs usages
KR20250004237A (ko) 아미노산의 생체이용률을 개선하기 위한 변형된 소포로지질 및 사용 방법
IL262602A (en) Amid derivatives of polycapoquinic acids, process for their preparation and uses
ATE341331T1 (de) Lipide zur änderung des abwehrsystems
CY1107006T1 (el) Συνθεση απο αλκανιοδικαρβονικα οξεα και μια φαρμακευτικη ουσια
WO2013068964A1 (en) Pharmaceutical composition for the prevention and the treatment of degenerative skin disorders especially caused by ionizing radiations
WO2013015288A1 (ja) リパーゼ活性阻害剤

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties